Search

Author/Creator Silverstein, Adam M.

1. Bronchodilation induced by PGE2 is impaired in Group III pulmonary hypertension. (31st October 2019)

Authors:
Ozen, Gulsev; Benyahia, Chabha; Mani, Salma; Boukais, Kamel; Silverstein, Adam M.; Bayles, Richard; Nelsen, Andrew C.; Castier, Yves; Danel, Claire; Mal, Hervé; Clapp, Lucie H.; Longrois, Dan; Norel, Xavier
Journal:
British journal of pharmacology
Issue:
Volume 177:Number 1(2020)
Page Start:
161
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Downregulation of PGI2 pathway in Pulmonary Hypertension Group-III patients. (September 2020)

Authors:
Ozen, Gulsev; Amgoud, Yasmine; Abdelazeem, Heba; Mani, Salma; Benyahia, Chabha; Bouhadoun, Amel; Tran-Dinh, Alexy; Castier, Yves; Guyard, Alice; Longrois, Dan; Silverstein, Adam M.; Norel, Xavier
Journal:
Prostaglandins, leukotrienes, and essential fatty acids
Issue:
Volume 160(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. In search of pulmonary hypertension treatments: Effect of 17β-estradiol on PGI2 pathway in human pulmonary artery. (September 2021)

Authors:
Amgoud, Yasmine; Senbel, Amira; Bouhadoun, Amel; Abdelazeem, Heba; Ozen, Gulsev; Savané, Ines; Manikpurage, Hasanga D.; Mani, Salma; Tran-Dinh, Alexy; Castier, Yves; Guyard, Alice; Longrois, Dan; Silverstein, Adam M.; Norel, Xavier
Journal:
Prostaglandins, leukotrienes, and essential fatty acids
Issue:
Volume 172(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗